RASINI, EMANUELA
 Distribuzione geografica
Continente #
NA - Nord America 4.864
EU - Europa 2.217
AS - Asia 1.616
SA - Sud America 283
AF - Africa 40
Continente sconosciuto - Info sul continente non disponibili 6
OC - Oceania 1
Totale 9.027
Nazione #
US - Stati Uniti d'America 4.803
IT - Italia 853
SG - Singapore 479
CN - Cina 390
UA - Ucraina 334
VN - Vietnam 246
BR - Brasile 245
SE - Svezia 239
TR - Turchia 215
DE - Germania 192
HK - Hong Kong 141
FI - Finlandia 124
GB - Regno Unito 115
IE - Irlanda 99
FR - Francia 96
RU - Federazione Russa 59
IN - India 40
MX - Messico 32
JP - Giappone 30
CA - Canada 24
BD - Bangladesh 21
PL - Polonia 21
ZA - Sudafrica 17
AR - Argentina 16
CZ - Repubblica Ceca 14
ES - Italia 14
BE - Belgio 12
NL - Olanda 10
AT - Austria 9
RO - Romania 8
EC - Ecuador 7
IQ - Iraq 7
NG - Nigeria 7
AE - Emirati Arabi Uniti 6
EU - Europa 5
MA - Marocco 5
PK - Pakistan 5
CO - Colombia 4
JO - Giordania 4
LT - Lituania 4
SA - Arabia Saudita 4
CL - Cile 3
EG - Egitto 3
IL - Israele 3
PY - Paraguay 3
VE - Venezuela 3
AL - Albania 2
CH - Svizzera 2
DZ - Algeria 2
ET - Etiopia 2
KZ - Kazakistan 2
LB - Libano 2
MY - Malesia 2
OM - Oman 2
PH - Filippine 2
PT - Portogallo 2
QA - Qatar 2
RS - Serbia 2
UZ - Uzbekistan 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AO - Angola 1
AZ - Azerbaigian 1
BG - Bulgaria 1
BO - Bolivia 1
CI - Costa d'Avorio 1
CR - Costa Rica 1
EE - Estonia 1
GD - Grenada 1
GY - Guiana 1
HN - Honduras 1
HU - Ungheria 1
ID - Indonesia 1
IR - Iran 1
KE - Kenya 1
KH - Cambogia 1
KR - Corea 1
KW - Kuwait 1
LV - Lettonia 1
MD - Moldavia 1
MN - Mongolia 1
NI - Nicaragua 1
NO - Norvegia 1
NP - Nepal 1
NZ - Nuova Zelanda 1
PA - Panama 1
TH - Thailandia 1
TJ - Tagikistan 1
TN - Tunisia 1
TW - Taiwan 1
Totale 9.027
Città #
Dallas 1.008
Milan 529
Chandler 397
Ashburn 319
Singapore 313
San Jose 296
Fairfield 287
Woodbridge 256
Jacksonville 255
Ann Arbor 220
Hong Kong 138
Houston 129
Seattle 128
Beijing 122
Wilmington 115
Nyköping 108
The Dalles 99
Dublin 98
Cambridge 96
Princeton 88
Izmir 87
Dearborn 73
Como 70
Los Angeles 70
New York 66
Dong Ket 65
Boardman 54
Rome 49
Helsinki 47
Lauterbourg 44
Munich 44
Hanoi 40
Ho Chi Minh City 40
Chicago 38
San Mateo 38
London 33
Frankfurt am Main 30
Tokyo 30
Des Moines 28
San Diego 27
Buffalo 24
Varese 24
Orem 23
Chennai 22
São Paulo 20
Mexico City 19
Warsaw 19
Council Bluffs 17
Ogden 17
Santa Clara 17
Denver 16
Johannesburg 16
Poplar 14
Atlanta 13
Brno 13
Brussels 12
Montreal 12
Guangzhou 11
Stockholm 11
Washington 11
Berlin 10
Brooklyn 10
Phoenix 10
Düsseldorf 8
Querétaro 8
Shanghai 8
Abuja 7
Amsterdam 7
Brasília 7
Columbus 7
Haiphong 7
Hangzhou 7
Manchester 7
San Francisco 7
Stuttgart 7
Tianjin 7
Hefei 6
Norwalk 6
Ponte Lambro 6
Ankara 5
Boston 5
Rio de Janeiro 5
Shenyang 5
Shenzhen 5
Verona 5
Vienna 5
West Jordan 5
Amman 4
Biên Hòa 4
Casorezzo 4
Da Nang 4
Franca 4
Guarulhos 4
Jinan 4
Recife 4
Redmond 4
Redwood City 4
Salvador 4
Sumaré 4
Toronto 4
Totale 6.539
Nome #
1-year statin treatment reverts the pro-inflammatory cytokine interleukin-8 release of primed neutrophils in dyslipidemic subjects 1.163
Relationship between regulatory T cells subsets and lipid profile in dyslipidemic patients: A longitudinal study during atorvastatin treatment 256
Parkinson's disease patients have a complex phenotypic and functional Th1 bias: Cross-sectional studies of CD4+ Th1/Th2/T17 and Treg in drug-naïve and drug-treated patients 227
Isoflavone content and estrogenic activity of different batches of red clover (Trifolium pratense L.) extracts: An in vitro study in MCF-7 cells 226
Angiotensin II type 1 receptor expression in polymorphonuclear leukocytes from high-risk subjects: changes after treatment with simvastatin. 222
Peripheral CD4+CD25+ Regulatory T-cell Frequency is Increased in High-Cardiovascular-Risk Subjects and is not Modified after 1-month Statin Treatment: a Longitudinal Study. 219
7-hydroxymatairesinol potassium acetate (Hmr/LignanTM) from Norway spruce (Picea abies) knots and its active metabolite enterolactone exert estrogenic effects in the in MCF-7 cell model. 216
Association between the circadian course of endogenous noradrenaline and the hematopoietic cell cycle in mouse bone marrow. 211
Characterization of human leukocyte-HUVEC adhesion: Effect of cell preparation methods 211
Angiotensin II type 1 receptor expression on human leukocyte subsets: a flow cytometric and RT-PCR study 208
Dopaminergic D-1-like receptor-dependent inhibition of tyrosine hydroxylase mRNA expression and catecholamine production in human lymphocytes 208
Adrenergic mechanisms in multiple sclerosis: the neuro-immune connection? 206
Estrogenic activity of 7-hydroxymatairesinol potassium acetate (HMR/lignantrade mark) from Norway spruce (Picea abies) knots and of its active metabolite enterolactone in MCF-7 cells. 204
Dopaminergic inhibition of human neutrophils is exerted through D1-like receptors and affected by bacterial infection 200
Prolonged statin-associated reduction in neutrophil reactive oxygen species and angiotensin II type 1 receptor expression: 1-year follow-up 197
Pain perception, blood pressure levels, and peripheral benzodiazepine receptors in patients followed for differentiated thyroid carcinoma: a longitudinal study in hypothyroidism and during hormone treatment 196
cAMP levels in lymphocytes and CD4+ regulatory T-cell functions are affected by dopamine receptor gene polymorphisms 196
Production of proinflammatory mediators by human neutrophils during long-term culture 194
Complex Changes in the Innate and Adaptive Immunity Accompany Progressive Degeneration of the Nigrostriatal Pathway Induced by Intrastriatal Injection of 6-Hydroxydopamine in the Rat 191
Dopaminergic modulation of oxidative stress and apoptosis in human peripheral blood lymphocytes: Evidence for a D1-like receptor-dependent protective effect 186
Angiotensin II Type1 and type2 receptor expression in circulating monocytes of diabetic patients over 3-month rosuvastatin treatment 172
Atorvastatin treatment influences polymorphonuclear leukocyte function: a longitudinal study. 171
Effects of atorvastatin treatment on the modulation of leukocyte function in patients undergoing peripheral vascular intervention: a longitudinal study 170
Treatment with simvastatin modifies AT1R expression and function in polymorphonuclear leukocyte of high cardiovascular risk subjects: a longitudinal study 170
Modifications of apoptosis-related protein levels in lymphocytes of patients with Parkinson’s disease. The effect of dopaminergic treatment 170
Il trattamento con rosuvastatina è associato ad una riduzione dell’espressione del recettore di tipo 1, ma non di tipo 2, dell’Angiotensina II in monociti circolanti di pazienti diabetici. 163
Patients with type 2 diabetes vs. non-diabetic high-risk subjects: effect of simvastatin on angiotensin II type 1 receptor mRNA expression in leukocytes 158
Effect of interferon-beta on endogenous catecholamines in human peripheral blood mononuclear cells: interaction with interferon-gamma and relevance for activation-induced apoptosis 156
Endothelial cell dysfunction in patients with peripheral artery disease. 155
Therapy with interferon-beta modulates endogenous catecholamines in lymphocytes of patients with multiple sclerosis 153
Angiotensin II Reduces the Suppressive Function of Human CD4+CD25+ Regulatory T Lymphocytes. 151
Angiotensin type1 receptor expression and Interleukin-8 production in polymorphonuclear leukocytes of patients with peripheral artery disease. 149
Beta1- and Beta2-Adrenoceptors Expression Patterns in Human Non-small Cell Lung Cancer: Relationship with Cancer Histology 148
Effecys of Natalizumab on CD4+CD25+FoxP3+ regulatory T lymphocytes in multiple sclerosis patients 144
Caratteristiche funzionali dei leucociti polimorfonucleati in pazienti dislipidemici: modificazione a 1 mese ed 1 anno di trattamento con simvastatina. 143
Terapia con statina in pazienti dislipidemici affetti da steatoepatite non alcolica: effetto su lipidi e funzione epatica. 142
Longitudinal evaluation of endogenous catecholamines and activation-induced apoptosis in lymphocytes from multiple sclerosis patients undergoing interferon-beta treatment 138
Reactive oxygen species generation and AT1-receptors during prolonged simvastatin treatment in neutrophils by dyslipidemic subjects 135
Interferon beta reverts the effects of interferon gamma on endogenous catecholamines produced by blood mononuclear cells from multiple sclerosis patients 135
effect of simvastatin on angiotensin II type 1 receptor mRNA expression in leukocytes: a longitudinal study in dyslipidemic subjects. 127
Relationship between circulating CD4+ T lymphocytes and cognitive impairment in patients with Parkinson's disease 123
Interferon-beta and interferon-gamma affect endogenous catecholamines in human peripheral blood mononuclear cells: implications for multiple sclerosis. 118
Expression of the ANG II Type 1 Receptor on human CD4+CD25+hi regulatory T cells 117
Reduction of Angiotensin II type 1 receptor mRNA expression on human leukocyte subsets after simvastatin treatment in high-risk patients 110
A peripheral blood mononuclear cell-based in vitro model: A tool to explore indoleamine 2, 3-dioxygenase-1 (IDO1) 105
Dopaminergic modulation of CD4+CD25high regulatory T lymphocytes in multiple sclerosis patients during interferon-β therapy 102
Do Th17 lymphocytes and IL-17 contribute to Parkinson's disease? A systematic review of available evidence 70
Dopamine inhibits human CD8+ Treg function through D1-like dopaminergic receptors 61
Effect of Cannabidiol on Human Peirpheral Blood Mononuclear Cells and CD4+ T Cells. 57
Modified Mediterranean diet effects on Parkinson’s disease (MED-PARK): a single-centre randomised controlled trial protocol 24
Totale 9.074
Categoria #
all - tutte 30.046
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 30.046


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021217 0 0 0 0 0 0 0 0 0 45 56 116
2021/2022517 46 71 45 42 36 8 24 22 29 77 57 60
2022/2023930 76 98 57 139 36 183 8 146 112 21 36 18
2023/2024966 132 125 143 194 169 103 1 15 22 13 15 34
2024/20251.000 17 25 150 58 34 56 84 73 71 115 111 206
2025/20263.058 221 334 783 384 304 179 434 148 173 98 0 0
Totale 9.074